… the progress of pancreatic cancer, acrossing metabolic reprogramming and key metabolic
pathways … At present, the hotspots of metabolic reprogramming of immune cells in pancreatic …

… metabolic reprogramming, and its contribution to immunotherapy resistance in pancreatic
cancer. … Regarding the metabolic reprogramming of pancreatic cancer cells in hypoxia, several …

Due to loss of p16ink4a in pancreatic ductal adenocarcinoma (PDA), pharmacological
suppression of CDK4/6 could represent a potent target for treatment. In PDA models, CDK4/6 …

… In a mouse pancreatic cancer model, ablating oncogenic Kras from established tumors
revealed a fraction of cells that survive and eventually propagate. These dormant cells display …

… tried to explain the mechanisms of abnormal cancer metabolism from the perspective of tumor
… metabolic reprogramming was regulated by tumor suppressor genes in pancreatic cancer …

… signaling promote protumorigenic events, including metabolic reprogramming with several
inter-… role of inflammatory signaling and metabolic reprogramming with emerging evidence of …

… Our results delineate the cellular metabolism reprogramming that starts early in PDAC
progression and demonstrate that such changes are consistently observed across different models…

During the progression of pancreatic ductal adenocarcinoma (PDAC), heterogeneous subclonal
populations emerge that drive primary tumor growth, regional spread, distant metastasis…

… involves glucose, lipid, and amino acid metabolism and … in metabolism during the progression
of pancreatic cancer and their … , and summarized current studies on metabolic inhibitors. …

… In this review, we highlight key findings and potential future directions of pancreatic
cancer metabolism research, specifically focusing on novel therapeutic opportunities. …